124 related articles for article (PubMed ID: 12816072)
21. Tumorigenesis in cells derived from induced pluripotent stem cells.
Nishimori M; Yakushiji H; Mori M; Miyamoto T; Yaguchi T; Ohno S; Miyake Y; Sakaguchi T; Ueda M; Ohno E
Hum Cell; 2014 Jan; 27(1):29-35. PubMed ID: 24122447
[TBL] [Abstract][Full Text] [Related]
22. In vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation.
Werbowetski-Ogilvie TE; Morrison LC; Fiebig-Comyn A; Bhatia M
Stem Cells; 2012 Mar; 30(3):392-404. PubMed ID: 22213600
[TBL] [Abstract][Full Text] [Related]
23. Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice.
Gordeeva OF; Nikonova TM
Cell Transplant; 2013; 22(10):1901-14. PubMed ID: 23051679
[TBL] [Abstract][Full Text] [Related]
24. Complement-dependent control of teratoma formation by embryonic stem cells.
Koch CA; Jordan CE; Platt JL
J Immunol; 2006 Oct; 177(7):4803-9. PubMed ID: 16982921
[TBL] [Abstract][Full Text] [Related]
25. Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants.
Bieberich E; Silva J; Wang G; Krishnamurthy K; Condie BG
J Cell Biol; 2004 Nov; 167(4):723-34. PubMed ID: 15545317
[TBL] [Abstract][Full Text] [Related]
26. Derivation and characterization of two genetically unique human embryonic stem cell lines on in-house-derived human feeders.
Kumar N; Hinduja I; Nagvenkar P; Pillai L; Zaveri K; Mukadam L; Telang J; Desai S; Mangoli V; Mangoli R; Padgaonkar S; Kaur G; Puri C; Bhartiya D
Stem Cells Dev; 2009 Apr; 18(3):435-45. PubMed ID: 18699724
[TBL] [Abstract][Full Text] [Related]
27. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
[TBL] [Abstract][Full Text] [Related]
28. Human embryonic stem cell lines derived from the Chinese population.
Fang ZF; Jin F; Gai H; Chen Y; Wu L; Liu AL; Chen B; Sheng HZ
Cell Res; 2005 May; 15(5):394-400. PubMed ID: 15916726
[TBL] [Abstract][Full Text] [Related]
29. The tumorigenicity of human embryonic stem cells.
Blum B; Benvenisty N
Adv Cancer Res; 2008; 100():133-58. PubMed ID: 18620095
[TBL] [Abstract][Full Text] [Related]
30. Pluripotency of spermatogonial stem cells from adult mouse testis.
Guan K; Nayernia K; Maier LS; Wagner S; Dressel R; Lee JH; Nolte J; Wolf F; Li M; Engel W; Hasenfuss G
Nature; 2006 Apr; 440(7088):1199-203. PubMed ID: 16565704
[TBL] [Abstract][Full Text] [Related]
31. Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site.
Morgan JE; Gross JG; Pagel CN; Beauchamp JR; Fassati A; Thrasher AJ; Di Santo JP; Fisher IB; Shiwen X; Abraham DJ; Partridge TA
J Cell Biol; 2002 May; 157(4):693-702. PubMed ID: 12011114
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of human embryonic stem cells after transplantation in immune-deficient mice.
Przyborski SA
Stem Cells; 2005 Oct; 23(9):1242-50. PubMed ID: 16210408
[TBL] [Abstract][Full Text] [Related]
33. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
[TBL] [Abstract][Full Text] [Related]
34. [Effect of mononuclear phagocytes on the differentiation of syngeneic, allogeneic and xenogeneic hematopoietic stem cells].
Kravtsov VI; Lasunskaia EB; Freĭdlin IS
Tsitologiia; 1987 Oct; 29(10):1156-60. PubMed ID: 2893477
[TBL] [Abstract][Full Text] [Related]
35. Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel.
Prokhorova TA; Harkness LM; Frandsen U; Ditzel N; Schrøder HD; Burns JS; Kassem M
Stem Cells Dev; 2009; 18(1):47-54. PubMed ID: 18393673
[TBL] [Abstract][Full Text] [Related]
36. [Progress on embryonic stem cells for the treatment of myocardial infarction].
Cai WJ; Zhu YC
Sheng Li Ke Xue Jin Zhan; 2004 Jul; 35(3):205-9. PubMed ID: 15469088
[TBL] [Abstract][Full Text] [Related]
37. Novel embryonic stem cells expressing tdKaede protein photoconvertible from green to red fluorescence.
Shigematsu Y; Yoshida N; Miwa Y; Mizobuti A; Suzuki Y; Tanimoto Y; Takahashi S; Kunita S; Sugiyama F; Yagami K
Int J Mol Med; 2007 Oct; 20(4):439-44. PubMed ID: 17786273
[TBL] [Abstract][Full Text] [Related]
38. [Factors that control the differentiation of stem cells. I. The change in direction of hematopoietic stem cell differentiation under the effect of differentiating T-lymphocytes].
Petrov RV; Man'ko VM; Khaitov RM; Riabova LV; Rudneva TB
Tsitologiia; 1979 May; 21(5):602-9. PubMed ID: 380088
[TBL] [Abstract][Full Text] [Related]
39. Derivation and characterization of canine embryonic stem cell lines with in vitro and in vivo differentiation potential.
Vaags AK; Rosic-Kablar S; Gartley CJ; Zheng YZ; Chesney A; Villagómez DA; Kruth SA; Hough MR
Stem Cells; 2009 Feb; 27(2):329-40. PubMed ID: 19038794
[TBL] [Abstract][Full Text] [Related]
40. Variation in the safety of induced pluripotent stem cell lines.
Miura K; Okada Y; Aoi T; Okada A; Takahashi K; Okita K; Nakagawa M; Koyanagi M; Tanabe K; Ohnuki M; Ogawa D; Ikeda E; Okano H; Yamanaka S
Nat Biotechnol; 2009 Aug; 27(8):743-5. PubMed ID: 19590502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
